Terumo BCT is a medical-technology company based in Lakewood, Colorado, that develops and manufactures equipment for collecting blood components, performing therapeutic apheresis, and producing cellular therapies. The company operates across more than 130 countries and employs over 8,000 people globally as part of Terumo Corporation, a Tokyo-based parent company founded in 1921.
The company's core offerings include the Spectra Optia Apheresis System, which treats conditions such as sickle cell disease, and the Quantum Flex Cell Expansion System, a platform for manufacturing CAR-T therapies. Terumo BCT's technical capabilities span blood component processing, therapeutic plasma exchange, cell expansion, and cellular therapy manufacturing. The company maintains partnerships with organizations including The Leukemia & Lymphoma Society and operates a global 'From the Heart' program focused on community education and empowerment.
